Membranous Nephropathy

• CLINICAL_TRIALS research · 2025-10-02
  Clinical Trial Update: A Study of Anti-CD19/BCMA Universal CAR-T Cell Therapy RD06-05 in Patients With Autoimmune Diseases. [EARLY_Phase 1]

  Phase 1 study evaluating anti-CD19/BCMA universal CAR-T cell therapy RD06-05 in autoimmune diseases; the trial is currently recruiting.

• CLINICAL_TRIALS research · 2025-09-11
  Clinical Trial Update: Personalized Rituximab Treatment Based on Artificial Intelligence in Membranous Nephropathy (iRITUX) [Phase 3]

  A Phase 3 clinical trial called iRITUX is testing AI-guided, personalized rituximab treatment for membranous nephropathy. The study is curre…

• CLINICAL_TRIALS research · 2025-08-22
  Clinical Trial Update: A Real World Study About PMN

  This clinical trial update shows a real-world study on Primary Membranous Nephropathy that is currently recruiting, sponsored by Wei Chen.

• CLINICAL_TRIALS research · 2025-07-31
  Clinical Trial Update: Impact of Dapagliflozin for the Regulation of Immunological Activity in Membranous Nephropathy [Phase 2]

  A Phase 2 clinical trial is planned to evaluate dapagliflozin for regulating immunological activity in membranous nephropathy; the study is …

• CLINICAL_TRIALS research · 2025-06-19
  Clinical Trial Update: A Study to Learn More About the Effects and Safety of JMT601 in Adults With Primary Membranous Nephropathy [Phase 2]

  A Phase 2 clinical trial evaluating JMT601 in adults with primary membranous nephropathy, sponsored by Shanghai JMT-Bio Inc., is currently n…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS research · 2025-06-11
  Clinical Trial Update: The BCMA/CD19 Dual Targeted CAR-T Cell in Participants With Autoimmune Kidney Diseases [Phase 1]

  Phase 1 clinical trial evaluating a BCMA/CD19 dual-targeted CAR-T cell therapy for autoimmune kidney diseases, currently recruiting.

• CLINICAL_TRIALS research · 2025-06-08
  Clinical Trial Update: Epithelial Dysmetabolism and Renal Fibrosis in ANCA Vasculitis

  A clinical trial update from Assistance Publique - Hôpitaux de Paris describes a study on epithelial dysmetabolism and renal fibrosis in ANC…

• CLINICAL_TRIALS research · 2025-05-31
  Clinical Trial Update: Evaluate The Efficacy, Safety, Pharmacokinetics And Pharmacodynamics Of EVER001 [Phase 1]

  A Phase 1 study is evaluating EVER001 for primary membranous nephropathy, focusing on efficacy, safety, pharmacokinetics and pharmacodynamic…

• CLINICAL_TRIALS research · 2025-04-24
  Clinical Trial Update: Nephrotic Syndrome Study Network

  Clinical trial update from the Nephrotic Syndrome Study Network indicating that the study is currently recruiting for conditions including M…

• CLINICAL_TRIALS research · 2025-04-11
  Clinical Trial Update: Optimization of a Decision Formula for Optimal Timing of Immunosuppressive Therapy Initiation in Primary Membranous Nephropathy: A Multicenter Retrospective Cohort Study

  A multicenter retrospective cohort study aiming to optimize a decision formula for the timing of initiating immunosuppressive therapy in pat…

• CLINICAL_TRIALS research · 2025-03-25
  Clinical Trial Update: A Clinical Study of B007 in the Treatment of Primary Membranous Nephropathy. [Phase 2, Phase 3]

  A Phase 2/3 clinical trial evaluating B007 for primary membranous nephropathy is currently recruiting, sponsored by Shanghai Jiaolian Drug R…

• CLINICAL_TRIALS research · 2025-02-10
  Clinical Trial Update: A Phase I Clinical Study of Recombinant Humanized Anti-CD20(B-lymphocyte Antigen CD20) Monoclonal Antibody Subcutaneous Injection in the Treatment of Primary Membranous Nephropathy [Phase 1]

  Phase I clinical trial evaluating a recombinant humanized anti-CD20 monoclonal antibody delivered by subcutaneous injection for primary memb…

• CLINICAL_TRIALS research · 2025-01-07
  Clinical Trial Update: Raman Spectroscopy Diagnosis of Kidney Diseases

  This update describes an ongoing clinical trial evaluating Raman spectroscopy as a diagnostic tool for kidney diseases, including IgA nephro…

• CLINICAL_TRIALS research · 2024-11-26
  Clinical Trial Update: IM19 CAR-T Cell Therapy for IgA Nephropathy Patients and Membranous Nephropathy Patients [EARLY_Phase 1]

  Early-phase (Phase 1) trial update for IM19 CAR-T cell therapy in IgA nephropathy and membranous nephropathy; the study is not yet recruitin…

• CLINICAL_TRIALS research · 2024-05-10
  Clinical Trial Update: Correlation and Clinical Utility of Urinary Biomarker in Membranous Glomerulonephritis

  An ongoing clinical trial is evaluating the correlation between a urinary biomarker and disease activity, and its potential clinical utility…

• CLINICAL_TRIALS research · 2024-04-25
  Clinical Trial Update: A Study of SNP-ACTH (1-39) Gel in Patients With Primary Membranous Nephropathy [Phase 3]

  Cerium Pharmaceuticals reports a Phase 3 clinical trial of SNP-ACTH (1-39) Gel for primary membranous nephropathy, currently recruiting.